Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMD14 | O00487 | 2/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.37 |
| ▸ | MMP2 | P08253 | 2/20 | 0.37 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.35 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25486732 | 0.94 | PSMD14 (0.39) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL25486733 | 0.94 | ACHE (0.39) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL25486413 | 0.94 | PSMD14 (0.39) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL25486847 | 0.94 | ACHE (0.39) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL27451291 | 0.94 | PSMD14 (0.39) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL25486415 | 0.94 | ACHE (0.39) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL27360099 | 0.94 | PSMD14 (0.39) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL25486581 | 0.94 | ACHE (0.39) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL27360103 | 0.94 | ACHE (0.39) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL25486205 | 0.94 | ACHE (0.39) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230233671-A1 | RNA MOLECULES | PFIZER INC. | 2023-07-27 | — | — | US | disclosed |
| US-20230233671-A1 | RNA MOLECULES | PFIZER INC. | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230233671-A1 | RNA MOLECULES | SNRPE, SNRPF, SNRPA | PSMD14 3877/4885PLA2G1B 308/4885MMP2 4461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.